Alexander V Egorov

Dr. Alexander V Egorov

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2013 in Geochimica et Cosmochimica Acta
Verified
Journal Article
Closed access
ARAnna Yu. Romanchuk
Anna Yu. Romanchuk
SKStepan N. Kalmykov
Stepan N. Kalmykov
AEAlexander V Egorov
Alexander V Egorov
Yan V. ZubavichusYan V. Zubavichus
Yan V. Zubavichus
ASAndrey A. Shiryaev
Andrey A. Shiryaev
IPIgor A. Presnyakov
Igor A. Presnyakov

15 February 2011 in The Journal of Physical Chemistry C
Verified
Journal Article
Closed access
LYL. V. Yashina
L. V. Yashina
AEAndrei A. Eliseev
Andrei A. Eliseev
Marianna V. KharlamovaMarianna V. Kharlamova
Marianna V. Kharlamova
AVA. A. Volykhov
A. A. Volykhov
AEAlexander V Egorov
Alexander V Egorov
ABA. I. Belogorokhov
A. I. Belogorokhov

1 May 2016 in Applied Surface Science
Verified
Journal Article
Closed access
Sergei ChernyakSergei Chernyak
Sergei Chernyak
ESEvgeniya Suslova
Evgeniya Suslova
AEAlexander V Egorov
Alexander V Egorov
KMKonstantin Maslakov
Konstantin Maslakov
SSSerguei V. Savilov
Serguei V. Savilov
VLValery V. Lunin
Valery V. Lunin

3 July 2023 in Ceramics International
Verified
Journal Article
Closed access
IKI.V. Kozerozhets
I.V. Kozerozhets
ESE.A. Semenov
E.A. Semenov
Varvara V. AvdeevaVarvara V. Avdeeva
Varvara V. Avdeeva
YIYu. D. Ivakin
Yu. D. Ivakin
SKStepan Kupreenko
Stepan Kupreenko
GPG.P. Panasyuk
G.P. Panasyuk

24 February 2022 in Catalysts
Verified
Journal Article
Open access
PDF file
SSSergey Sergeevich Shapovalov
Sergey Sergeevich Shapovalov
NMNatalia A. Mayorova
Natalia A. Mayorova
Alexander ModestovAlexander Modestov
Alexander Modestov
ASAndrey A. Shiryaev
Andrey A. Shiryaev
AEAlexander V Egorov
Alexander V Egorov
VGVitaly A. Grinberg
Vitaly A. Grinberg
Nanosized bimetallic PtMo, PtFe and trimetallic PtMoSn catalysts deposited on highly dispersed carbon black Vulcan XC-72 were synthesized from the cluster complex compounds PtCl(P(C6H5)3)(C3H2N2(CH3)2)Mo(C5H4CH3)(CO)3, Pt(P(C6H5)3)(C3N2H2(CH3)2)Fe(CO)3(COC6H5C2C6H5), and PtCl(P(C6H5)3)(C3N2H2(CH3)2)C5H4CH3Mo(CO)3SnCl2, respectively. Structural characteristics of these catalysts were studied using X-ray diffraction (XRD), microprobe energy dispersive spectroscopy (EDX), and transmission electron microscopy (TEM). The synthesized catalysts were tested in aqueous 0.5 M H2SO4 in a three-electrode electrochemical cells and in single fuel cells. Electrocatalytic activity of PtMo/C and PtFe/C in the oxygen reduction reaction (ORR) and the activity of PtMoSn/C in electrochemical oxidation of ethanol were evaluated. It was shown that specific characteristics of the synthesized catalysts are 1.5–2 times higher than those of a commercial Pt(20%)/C catalyst. The results of experiments indicate that PtFe/C, PtMo/C, and PtMoSn/C catalysts prepared from the corresponding complex precursors can be regarded as promising candidates for application in fuel cells due to their high specific activity.

29 May 2022 in Colloids and Interfaces
Verified
Journal Article
Open access
PDF file
STShen Tianyi
Shen Tianyi
Maria G. ChernyshevaMaria G. Chernysheva
Maria G. Chernysheva
GBGennadii Badun
Gennadii Badun
APAndrey G. Popov
Andrey G. Popov
AEAlexander V Egorov
Alexander V Egorov
NBNatalia P. Bakuleva
Natalia P. Bakuleva
This research is focused on the adsorption modification of detonation nanodiamond surfaces with antibiotics for their further use as smart materials for cardiovascular surgery purposes, namely as bioprostheses modifiers. Tritium-labeled amikacin and levofloxacin were used as tracers for the adsorption process control. We found that nanodiamonds form adsorption complexes with levofloxacin via physical adsorption, while in the case of amikacin, electrostatic attraction contributes to the formation of more stable complexes, even in the presence of electrolytes and desorbing agents (models of biological fluids). Antimicrobial characterization of nanodiamond–levofloxacin and nanodiamond–amikacin complexes indicates a reduction in the dose of antibiotics that is used as an antimicrobial agent. Therefore, the use of biomaterial based on DND complexes with antibiotics as the basis of bioprostheses will allow one either to avoid or significantly reduce the duration and intensity of antibiotics use in the postoperative period, which is critically important from the viewpoint of the development of antibiotic resistance in pathogens.